Search

Outlook brightens for regenerative medicine

Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, things are looking up for regenerative medicine. Now further support is needed to deliver on the therapeutic potential, experts say in a Science|Business Webinar
News

Plotting the shifts in Europe’s innovation ecosystem

Academics, SMEs and large companies are doing much more research in partnership. Science|Business looks back at some of the highlights of the move to open innovation in 2012, and the policy initiatives that are supporting this
News

European cell therapy pioneer makes further advance

This week TiGenix reported positive safety data for its stem cell therapy for rheumatoid arthritis. The news highlights the potential of regenerative medicine as Science|Business publishes a special report examining how Europe can build on its leading position in this fast-paced field of research
News

Experts debate the future of stem cells

Europe is currently a world leader in the fundamental science underpinning regenerative medicine and cell therapy, and in its therapeutic use and regulation. But how can Europe build on its leading position?

Report
Free